Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
NCT07853807
This study is recruiting at 5 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
In Study 1, investigators will test the ability of each of the seven paradigms to differentiate between schizophrenia (SZ)/schizoaffective disorder (SZA) and matched healthy control subjects (HC) and to predict individual differences in clinical measures of hallucinations and delusions (as well as measures of function). Investigators will also directly compare the tasks in terms of predictive ability and psychometric properties and determine whether the tasks share variance or explain unique variance.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- SCHIZOPHRENIA 1 (Disorder)
- Schizoaffective Disorder
- Healthy Adult Participants
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 18 to 59 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Washington University School of Medicine
- Last updated on ClinicalTrials.gov
- October 2, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- University of California, Irvine · Irvine, CA
Illinois · 1
- The University of Chicago · Chicago, IL
Maryland · 1
- University of Maryland, Baltimore · Baltimore, MD
Minnesota · 1
- University of Minnesota · Minneapolis, MN
Missouri · 1
- Washington University · St Louis, MO
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.